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ABSTRACT

E-LIQUID EXPOSURE CAUSES MULTIPLE CARDIOVASCULAR DEFECTS
IN XENOPUS LAEVIS EMBRYOS
By James E. Black III, B.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science in Biology at Virginia Commonwealth University.
Virginia Commonwealth University, 2020
Major Advisor: Amanda Dickinson, Ph.D. Associate Professor, Department of Biology

Over the past several years vaping has become part of the cultural zeitgeist in the United
States, with ECIG usage amongst those of reproductive age rising more and more. Due to a lack
of regulation and research concerning their long term effects, public opinion trends toward the idea
that they are somehow safer than their traditional counterparts. As cases of lung injury and ECIG
related death are beginning to be reported more and more, it is clear that the misinformation about
their safety is unfounded. Congenital heart defects (CHDs) are some of the most common birth
defects currently in the United States. Increased risk of these conditions is known to be associated
with traditional cigarette use, but information concerning the relationship between these conditions
and electronic cigarette use is not readily available, highlighting an area in need of study. Xenopus
laevis is an ideal model to evaluate the effects of ECIG exposure on cardiac, blood, and vasculature
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development due to the familiarity with the X. laevis genome, their transparent nature, and their
ex utero development all of which make alterations to development easy to evaluate throughout
multiple stages.
In this study, I show that e-liquid exposure during development reduces ventricle size
and heart rate as well as altering the expression of several cardiac, blood, and vasculature related
genes in X. laevis embryos. Additionally, I suggest that these effects are not simply due to
nicotine or frequent e-liquid additives propylene glycol and vegetable glycerin, but some other
chemicals used in e-liquid.

ix

1. Introduction

The most common types of birth defects, affecting roughly 40,000 births each year in the
United States, are a group of cardiovascular disorders referred to as congenital heart defects
(CHDs) [22]. Roughly 2 million Americans between infancy and adulthood are currently living
with CHDs. They remain the leading causes of perinatal mortality, with a current incidence rate
of roughly 8% of live births globally. CHDs put a major financial and emotional strain on
individuals living with them and their families, as they are synonymous with high out-of-pocket
medical costs and a decrease in mental health [21]. One factor lending itself to high numbers of
these congenital conditions is traditional cigarette use during pregnancy. Maternal prenatal
cigarette use has a teratogenic effect on cardiovascular development, with children having a 10%
relative increase in the risk of being born with a CHD, including septal and atrioventricular
defects [23-24]. Over the last 12 years, a new method of smoking has continued to gain
popularity in the United States as electronic cigarette (ECIG) use climbed over 78% from 2017
to 2018. This accompanied a decrease in traditional cigarette use, attributed to the way ECIGs
are marketed as well as the misinformation about their safety [6]. ECIG use is particularly
dangerous as there is little regulation and a major gap in information concerning their long term
effects. ECIGs pose a unique threat as they tout a long list of additives in addition to the nicotine
found in traditional cigarettes. Due to the relationship between traditional cigarettes and the
increased risk of CHDs, it is important to examine the relationship between ECIGs and these
same heart conditions. It follows logically that there is a high potential for ECIGs to result in
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similar heart defects as their traditional counterparts, made even more urgent because of the
misconception that they are safer.

1.1 Electronic cigarettes and their use
ECIGs are electronic devices that use an atomizer to aerosolize liquid products,
often loaded as cartridges. These liquids contain nicotine, flavoring additives, and a humectant
used to maintain moisture in the mixture [14]. Even though electronic cigarettes and vaping are
still relatively new, the number of users is rapidly rising as it becomes normalized behavior.
These devices are being hailed as a healthier, more socially acceptable method of smoking, and
can be seen everywhere from designated outdoor smoking areas to school hallways, and
restaurants. This prevalence is not entirely unexpected considering how these devices are
marketed, and to whom they are marketed to. With a myriad of flavors made available ranging
from tobacco and menthol to children's cereals and fruity cocktails, these substances seem to
specifically be targeting adolescents, including women of reproductive age. This is a source of
concern as studies show that roughly 15% of pregnant women are currently using ECIGs, with
43-88% of those women considered dual users –using both electronic and traditional cigarettes.
Almost all women who used ECIGs reported doing so because of a sense of perceived harm
reduction and as an aid in cessation from traditional cigarettes. In actuality, ECIG use tends to
renormalize traditional cigarettes and perpetuate nicotine addiction [3].
While some of the chemicals that are in the e-liquids may be non-hazardous alone when
aerosolized they become oxidized. This alters them in such a way that they become harmful,
often converting into known carcinogens. ECIG vapor exposure has been shown to be cytotoxic
to human stem cells, a fact that only further negates the wealth of public misinformation [11].
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1.2 Emerging dangers of vaping
Prior to 2016, there was no FDA involvement in e-cigarette regulation. For this
reason, there was no requirement for warning labels on e-liquid packaging detailing the dangers
of nicotine during pregnancy [25]. This, coupled with the fact that ECIGs have been marketed as
being less harmful than traditional cigarettes, has painted a very misleading picture [26]. As of
February 2020, there have been 68 deaths due to vaping-related illnesses. In addition, 2,807
cases of ECIG related lung injury have been documented in the United States. These numbers
continue to rise as more states are reporting [47]. In addition, there is mounting evidence from
research studies in cell lines and animal models that vaping is not safe. For example, vaping or
ECIG exposure has been shown to cause lung damage, increased angiogenesis, decreased heart
rate and increased risk of cancer risk in rats and mice [15]. Deleterious effects on mucous
membrane function and alteration of gene expression in numerous organs indicating increased
cancer risk have also been observed [26]. From these studies, it is still not clear what components
of e-liquids could be causing these problems. One possibility is the flavoring chemicals. For
example, we know that the additive, diacetyl, causes bronchitis obliterans, commonly known as
popcorn lung [1]. This chemical gives the vapor a "buttery" flavor when heated. This condition
causes the bronchioles of the lungs to become irritated and can decrease their diameter causing
complications and making it harder to breathe. This is the same flavoring that was once used in
microwavable popcorn manufacturing, with many companies moving away from it after their
employees presented large case numbers of bronchitis obliterans. Despite this, it continues to be
used in some e-cigarette flavoring [2].
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1.3 Dangers during development
Several studies suggest that ECIGs could have detrimental effects both to the user as well
as their unborn children. Embryonic cells may be even more sensitive to ECIG solutions than
adult cells. For example, some ECIG liquids were shown to be cytotoxic to human embryonic
stem cells while having no effect on adult pulmonary cells [43]. ECIG exposure caused low fetal
weight in rats and mice, an indicator of other complications and perinatal morbidity [17].
Electronic cigarette exposure has also been observed to have negative effects on neural
development. Rats born to mothers exposed to aerosolized e-liquids had significant changes in
the expression of genes in the frontal cortex. These observed alterations in the central nervous
system transcriptome are associated with negative neurobiological outcomes in humans,
including a decrease in cognition and memory function [19].
Developmental concerns of ECIG exposure also extend to the cardiovascular system.
Some aerosolized e-liquid vapor solutions were cytotoxic to fetal rat cardiomyoblast cell lines
[16], and components of aerosolized e-liquids have been shown to negatively affect
cardiovascular development in Zebrafish as well. Danio rerio exposed to aerosolized e-liquid
solution presented high frequencies of heart abnormalities not observed in embryos exposed to
nicotine alone [14, 18]. Embryos exposed to particulates showed severe anatomical and
physiological abnormalities including mortality, delayed development, decreased oxygen
consumption, decreased heart rate and hemorrhaging. Altered angiogenesis was also observed,
with some blood vessels being completely absent [18]. One of the main components of ECIG
solutions called propylene glycol produced detrimental effects in Zebrafish when embryos were
exposed in vivo, including reduced growth, increased fluid in the pericardial sac, and
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hyperactivity in larvae. When exposed to aerosolized propylene glycol, Zebrafish embryos had a
“heart-string” phenotype in which the heart failed to loop properly [31].
Previous studies have shown that e-liquid exposure resulted in a reduction of blood cells
in the orofacial region of 100% of developing X. laevis embryos when compared to an
unexposed control [1].

1.4 Transcriptome analysis of faces exposed to e-liquids
An aerosolized mixture containing only nicotine, propylene glycol, and vegetable
glycerin was shown to have a dose-dependent, statistically significant effect on craniofacial
development in X. laevis, especially the shape of the orofacial region [1]. The inclusion of flavor
additives to these basic aerosolized mixtures can have varying degrees of severity on craniofacial
development, some of which can result in cleft palate. To help the lab determine how e-liquids
could be affecting gene expression in the face, the transcriptomic changes were evaluated in
microdissected faces using next-gen sequencing (RNAseq) (manuscript in prep). The top genes
in the facial tissue that were decreased were all related to blood. One such gene, gata1, codes for
an important transcription factor necessary for the normal production of blood cells; specifically
erythrocytes and platelets through the process of hematopoiesis. gata1 knockout in mice leads to
immature progenitor cells that are unable to properly differentiate and mature [4-5]. Mutations
within the gata1 gene are associated with CHDs [27]. The results of this RNA-seq analysis have
led to an investigation of the effect that e-liquid exposure has on blood supply in Xenopus laevis,
through the processes of both erythropoiesis and angiogenesis, as well as the morphological
development of the heart.
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1.5 Benefits of Xenopus laevis as the developmental model
The use of Xenopus laevis as the model in which this study will be conducted is
innovative since it allows a variety of experiments to be done quickly and efficiently, ascribable
to their rate of development. The current frog populations in the lab, coupled with the fact that
these frogs can give up to several thousand eggs, 3-4 times a year translates to an almost "ondemand" supply of embryos so that experiments can be repeated frequently and at very large
sample sizes.
The fact that they are ex utero enables me to observe and record important developmental
stages in real-time, with very clear visual detail. As X. laevis develop, their skin is translucent
enough to discern developing organs, not limited to the heart. This makes visualizing blood using
both a light microscope as well as GFP-microscopy in transgenic lines easy.
One common criticism of the use of these organisms relates to the fact that they are ex
utero, unlike humans. This allows for a wide variety of experiments to be performed and realtime observations to be made that would otherwise be impossible, or require more complex
methodology. Another frequent misconception about the use of X. laevis is that observations in
developmental dysfunction due to teratogens in these organisms are somehow different than
those in humans, but this is not the case. There are numerous United States Government-funded
studies specifically using X. laevis embryos as an indicator for possible toxic effects of
pharmaceuticals or environmental teratogens on mammals. Several side-by-side studies have
shown that certain teratogens have the same effects in both X. laevis and mice, strengthening our
conviction that the data generated in this study will have the potential to be very relevant to
public health [38-39]. Furthermore, as I am interested in prenatal effects of e-liquids wherein the
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human embryo would be exposed via the placenta, X. laevis is once again an effective model as
their embryonic dermal layer shares similar surface ion channels and transporters with the human
placenta, helping to predict how e-liquid products would travel across these barriers [9, 10].
Finally, X. laevis, has been used in the past to model respiratory epithelium, as their skin contains
cells capable of secreting mucus that act as a form of protection to the embryo. This is similar to
how the ciliated epithelial cells of the human lungs act as a barrier to allow for the exchange of
nutrients while protecting the body from pathogens. The similarity in structure and function
between these two tissue types could give me stronger predictive capabilities about the behavior
of ECIG products across the human lung. The ability to fertilize embryos in vitro allows me to
generate an abundant amount of synchronized data between sibling embryos, granting a view of
the differences in development between control and exposed embryos congruently. X. laevis are
useful models for cardiac development because of their similarity in cardiogenesis in humans
and might be even more useful that other model organisms for evaluating potential CHDs [27].

1.6 Heart development in X. laevis
X. laevis has a three-chambered heart with two atria and a single ventricle. This single
ventricle resembles the mammalian left ventricle and is responsible for pumping oxygenated
blood into the systemic circulation. Although the amphibian heart is structurally different from
mammalians, the basic developmental mechanisms that underlie the formation of this structure
are similar. The development of the heart starts at Stage 10, between 9 and 11 hours postfertilization (hpf), during gastrulation. By stage 12 (~13 hpf) cardiac progenitor cells within the
lateral plate mesoderm, located on both the left and right sides of the embryo, will begin to move
toward the ventral midline at the anterior of the embryo. Once these cells meet at the midline by
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stage 13 (~15 hpf) they fuse and soon after separate to give rise to the two heart fields. The first
heart field forms the two atria and the ventricle of the heart. The second heart field gives rise to
the outflow tract that is responsible for pumping blood into the systemic circulation. Between
Stages 31 and 33 (~37-34 hrs pf) these cardiac progenitor cells join to form the primary heart
tube [27].
For these cardiac progenitor cells to become functional cardiomyocytes, they must
undergo the process of differentiation. This begins when endoderm tissue starts secreting bone
morphogenetic proteins (BMP). BMP receptors activate Smad proteins initiating the
transcription of several heart-specific transcription factors such as GATA5, Nkx2, and Nkx5.
These transcription factors then regulate the expression of cardiac-specific genes that enable
cardiac cells to contract. Myocd is one such transcription factor that specifically regulates the
differentiation of cardiac and smooth muscle, and cardiac gene expression [53]. Additionally,
heart development relies on the inhibition of certain signaling pathways. For example, Dkk1
inhibits Wnt/β-catenin signaling during specific early heart development stages. This inhibition
ensures that proper differentiation takes place, as well as the controlled formation of important
anatomical structures such as the outflow tract [52].
At stage 33 the primary heart tube is a linear structure that begins extending posteriorly.
The ventricular portion of the heart tube lies anteriorly to what will become the atria at this point
in X. laevis development. Cardiac muscle contraction takes place at stage 35 (~44-50 hpf) [27].
This contraction encourages the linear structure to loop, forming a spiral structure with the
presumptive atrium moving dorsally to the ventricular portion [45]. This movement continues
until the atrial region is located medially while the ventricular portion moves to the right and is
displaced laterally eventually descending, residing in the pericardial cavity. This looping
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continues until stage 40 when the atrial region of the heart tube comes to rest directly dorsal to
the ventricular region. This process is regulated by the Xnr1 gene that controls the expression of
BMP, which is expressed during the looping process solely on the left side of the linear heart
tube. This gives the entire process conserved directionality and ensures proper looping to
maintain function and form [46]. Finally, between stages 40-46 (~66-106 hrs pf) the looped heart
tube begins to form individual chambers and the atria are finally separated into two independent
structures [27] (Table 1 A.)

1.7 Vasculature development in X. laevis
Vasculogenesis begins with the differentiation of ventral and lateral plate mesoderm into
hemangioblasts regulated by FGF signals. This occurs when FGF2 binds its receptor causing
mesodermal cells to begin transcribing VEGFR2/Flk1 receptors during neurulation around stage
15. When VEGF in the cell environment binds these receptors, it promotes the formation of
hemangioblasts, which become subdivided into the primitive blood islands. These blood islands
go on to form the blood as well as endothelial cells, which will become the vasculature. During
stages 27-32 of X. laevis development (31 - 40 hpf), VEGF binds its receptor (Flk1) on
presumptive endothelial cells and this signaling pathway regulates their migration and
differentiation into strands of cells. Next, VEGF stimulates the hemangioblasts to begin
transcribing Flt1 receptors which in turn will bind VEGF leading to the promotion of tube
formation. Tubes are ultimately formed from these strands of endothelial cells by the coalescence
of many vacuoles into a single lumen. These newly formed tubes assemble into a primitive
network or plexus and by stage 35 in X. laevis, circulation begins.
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Next, this primary network is remodeled through angiogenesis where vessels use
“filopodia” on Tip cells to reach out and connect with one another, originating and extending
from previously established vessels [61]. This process is regulated by PDGF and TGF-β
signaling, ensuring that the Tip cells can properly navigate their environment and ensure that
vessels fuse with their complement. This is also regulated by Delta notch signaling, with higher
Notch stimulation apparent in arteries compared to lower levels in veins.
By stage 46 much of the remodeling is complete and the principal blood vessels are
formed [64-65] (Table 1 C).

1.8 Blood development in X. laevis
The early embryonic blood ultimately forms from the blood islands arising from the
ventral mesoderm, before transitioning to the dorsal lateral plate (DLP) and dorsal aorta as
development continues. Unlike the blood islands, the DLP contributes solely to the adult
hematopoietic lineages [68].
Precursors to both immature and adult blood cells can first be seen at stage 6, at the 32cell embryo stage. Cells destined to become the ventral blood island (VBI) begin collecting
together and migrating ventrally during gastrulation between stages 10-14 (9 - 16 hpf). After
being exposed to BMP the blood island precursors begin to express hematopoietic genes causing
these tissues to begin differentiating into endothelial cells as well as the stem cells that will
eventually give rise to blood cells between stages 14-18 (16 - 20 hpf) [69]. These hematopoietic
stem cells will continue to differentiate in response to a great number of erythroid transcription
factors like Runx1, which works to convert endothelial cells into blood stem cells. Runx1
expression is regulated by an intricate network of erythroid transcription factors such as SCL,

10

that works to ensure primitive blood cells are not converted to cardiac muscle, as well as GATA2
and Fli1. Runx1 is also important in the formation of megakaryocytes that will eventually mature
to become platelets through its coexpression and interaction with GATA1 [66-68]. GATA1 is a
transcription factor that is necessary for the normal production and maintenance of both RBCs
and platelets. GATA1 expression, like GATA2 and SCL, is first triggered by BMP signaling.
GATA1 does not work alone, as it must first complex with its cofactor FOG1 to function
properly. Knockdown experiments of either GATA1 or FOG1 were shown to have lethal effects
due to the lack of formation of megakaryocytes and platelets [66]. GATA1 also works to ensure
the survival of red blood cells by regulating the expression of genes that alter the cell cycle to
avoid apoptosis. One example is the stimulation of Bcl-Xl, an antiapoptotic protein [67].
The VBI finishes forming by stage 30 and is the primary site of hematopoiesis between
stages 26-40. By stage 35 though the blood is still considered to be “primitive” circulation
begins. Meanwhile, cells from the DLP have begun to migrate toward the midline, and after
expressing the Flk1 receptor will form the dorsal aorta (DA) by stage 38 (~53 hpf) [70]. After
stage 40 the VBI no longer exists, and the hematopoietic clusters within the DA become the site
of blood development and the establishment of the adult lineages [69].
Blood cells mature over a period of 26 days, and by stage 52, adult RBCs begin to
appear in circulation. Immature erythrocytes continue to be replaced by mature erythrocytes
throughout metamorphosis. At stage 60, half of the primitive blood cells will have been replaced
by mature RBCs, but the conversion process will continue well past metamorphosis. Sixth
months after X. laevis adult’s complete metamorphosis, the primitive erythrocytes have all been
replaced by mature, functioning RBCs as the source for production changes [44]. As X. laevis
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mature through metamorphosis the liver becomes the primary location for hematopoiesis, and
then through adulthood that site becomes bone marrow [29-30] (Table 1 B).

Based on preliminary evidence in X. laevis and zebrafish, I propose that e-liquid exposure
could affect cardiovascular development. Here in this thesis, I show that exposure to a popular
flavored e-liquid causes abnormality in heart morphology and function, as well as blood
distribution, and vascular arrangements. The effects on heart development may not be due
merely to nicotine, or inert carriers since these alone had little effect on heart development.
Further, both neat and aerosolized e-liquid preparations can result in similar effects on heart size
suggesting that heating the e-liquids may not alter them to create any dangerous chemicals.
Finally, e-liquid exposure can alter the expression of some cardiovascular regulatory genes.
Thus, I have begun to uncover mechanisms to explain why these defects occur.
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2. Methods and Materials
2.1 Animals
Using protocols described in Sive’s laboratory manual, an adult female frog was injected
with human chorionic gonadotropin (HCG) to induce egg laying. Eggs were then collected,
fertilized and cultured using standard protocols [83]. Tadpoles were staged according to
Niewekoop and Faber [84]. All experiments were performed following the approved IACUC
protocol AD20261.

2.2 E-liquid exposures in Xenopus laevis embryos
Beginning at stage 4, embryos were cleaned and sorted to remove any unfertilized eggs
as well as any embryos failing to divide. When embryos reached staged 20-24, they were
pipetted using a large-bore plastic transfer pipette into sterile Petri dishes or culture plates
containing 0.1X Modified Barth’s Saline (MBS). Experimental solutions were added to the
solution and the mixtures containing embryos were gently swirled. Chemical exposures
consisted of neat Revel (1:1000, Cloud Company), aerosolized Revel (1:100, [1]), nicotine
(10mg/ml), and aerosolized nicotine +PG+VG (1:100, [1]). Embryos were then incubated at
23°C. In some experiments, embryos were removed from exposure at stage 30 and processed for
PCR (see section 2.8). Alternatively, embryos were exposed until stage 40. After this, they were
removed and placed into 0.1xMBS until stages 45 - 46. At this time X. laevis embryos were
processed for heart morphology (section 2.6 - 2.7), heart rate (section 2.5), blood and vascular
assessments as described below (section 2.3 - 2.4) (Fig. 1.)
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2.3 Histological blood label (o-Dianisidine staining)
The staining solution consisted of 120mL dH2O, 80mL EtOH (DeconLabs: V1016),
1.3mL 30% Hydrogen Peroxide (MilliporeSigma: HX0635-3), 0.12g Sodium Acetate (Sigma
Aldrich: S2889-250G), and 0.16 o-Dianisidine (Sigma Aldrich: D9143), referred to as "Odianisidine solution." The solution works as a marker for blood development as the hemoglobin
present in fully mature red blood cells catalyzes the Hydrogen Peroxide to begin oxidizing oDianisidine to produce a dark red stain in any hemoglobin positive cells. After the standardized
Revel exposure (Fig 1) embryos were fixed for 20 minutes in 4% paraformaldehyde (PFA). They
were then placed in 1.5mL Eppendorf tubes and washed in phosphate-buffered saline solution
with Tween (PBT) 3 times for five minutes each. All of the PBT was removed and replaced by
1.5mL of the O-Dianisidine solution to ensure the embryos were covered. The solution needs to
be mixed at room temperature for at least 20 minutes before adding. The effect of the solution
warming in the Eppendorf tube causes them to burst, leading to possible damage to the samples
and inconsistent staining. The tubes were wrapped in foil and left mixing for 40 minutes.
Embryos were washed in PBT twice for two minutes each, and then all PBT should be removed.
The embryos were incubated in 4% PFA for 24 hours at 4°C while still covered in foil. Embryos
were washed again in PBT, 3 times for 5 minutes each, and then 70% glycerol (Biotech:
GB0232) was added and embryos were imaged on white clay (Zeiss Discovery V8 Axiocam 503
Color using Zen software.)

2.4 Transgenic X. laevis experiments
Transgenic X. laevis used to visualize vascular (XB-LINE-916, Flk1-GFP, FLK-1;
Xla.Tg(flk1:GFP)1Mead) and blood (XB-LINE-1216, Xla.Tg(gata1:GFP)Mead) development
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were ordered from Marine Biological Laboratory. The anterior of the embryos were imaged
using Zen software from a ventral and lateral view using 1% agarose as a base (Excelitas
Technologies: X-Cite Series 120 Q, Zeiss: Discovery V8 SteREO, Carl Zeiss Microimaging
GmbH.)

2.5 Heart rate
Light microscopy was used to image and record heart rates of both Revel exposed and
control embryos (Zeiss Discovery V8 Axiocam 503 Color using Zen software.) First, the
standardized Revel exposure protocol was used to treat embryos (Fig 1.) The embryos were
washed in 0.1xMBS and allowed to progress to stage 45. 500 µM Tricaine (Western Chemical:
051819) in 0.1xMBS was set out for twenty minutes and allowed to reach room temperature.
Working in groups of five (five exposed and five control) embryos were then to be placed into
the 0.1xMBS Tricaine solution for twenty minutes to acclimate to the dish temperature. Heart
rates, measured in beats per minute, were assessed by counting the number of beats for 30
seconds and then multiplying by two. The mean heart rate for each of the experimental
conditions is assessed. To control for any possible differences in stage, time, or temperature the
experimental mean was divided by the control mean to establish a relative change in heart rate.

2.6 Light microscopy
After experimental embryos are exposed to the Revel solution using the standardized
protocol (Fig 1), the embryos were washed in 0.1xMBS and allowed to mature to stage 45. At
stage 45 embryos were fixed in 4% PFA and imaged using a stereoscope (Zeiss Discovery V8
Axiocam 503 Color using Zen software.)
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2.7 Anti-Troponin T-C (CT3) staining
After experimental embryos are exposed to the Revel solution using the standardized
protocol (Fig 1), embryos were washed in 0.1xMBS and allowed to reach stage 45, at which
point they were fixed in 4% PFA overnight at 4°C. Embryos were then placed into 1.5mL
Eppendorf tubes, limiting each tube to 10 embryos. The fixative was removed and replaced with
PBT. Embryos were left in fix for 24 hours, no more and no less, as any variance, limits the
efficacy of the stain or causes them to deteriorate respectively. The embryos were then washed in
PBT three times for one hour. During the final wash, a primary antibody solution consisting of
20µl of CT3 antibody (Developmental Studies Hybridoma Bank: AB_528495) in 500µl of PBT
was prepared for each tube containing embryos. After the final wash, all of the PBT was
removed from the tubes and then 0.5ml of the primary antibody solution was added. The
embryos were left in the primary antibody solution at 4°C for seven days. After seven days, the
primary antibody solution was removed and replaced with PBT. Three washes of one hour were
performed. During the final wash, a 1:500 secondary antibody solution was prepared by adding
2µl of green fluorescent secondary antibody Alexa 488 goat anti-mouse (ThermoFisher: A11001) in 1mL of PBT. After the final wash, all of the PBT was removed and replaced with
0.5ml of the secondary antibody solution. At this point, the reaction is highly light-sensitive, so
tubes were promptly covered with foil. The embryos were kept in the secondary antibody
solution at 4°C for six days. Next, the secondary antibody solution was removed, and the
embryos were washed three times in PBT for at least one hour each. The embryos were
equilibrated in series in 50% glycerol until the embryos sank to the bottom of the Eppendorf
tube. Next, the 50% glycerol was removed, and 75% glycerol was added. Once again time was
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taken to allow the embryos to sink. Once the embryos sank, they were imaged in 75% glycerol
using 1% agarose as a base (Excelitas Technologies: X-Cite Series 120 Q, Zeiss: Discovery V8
SteREO, Carl Zeiss Microimaging GmbH.)

2.8 RT-PCR experiments
At stage 20-24, X. laevis embryos were randomly split into two groups and placed into
25mL of 0.1xMBS. The experimental groups were exposed by adding 25µl of neat Revel
solution and then incubated at 23°C until stage 30 for early heart markers and early gata1
experiments, or stage 40 for later stage gata1 experiments. They were then washed in 0.1xMBS
and placed into 800µl of Trizol (Ambion Fisher: 15596026) that was resting in ice. The embryos
were incubated for 10 minutes in the lab at room temperature (24°C) and then stored in a -80°C
freezer overnight for roughly 24 hours. The next day the tissue was thawed on ice and then
“homogenized” using both pestles and a Fisherbrand™ Mini Vortex Mixer (Fisher Scientific:
14-955-151) to begin the RNA extraction process. Next, the resulting mixture was centrifuged at
max speed for 10 minutes, and roughly 800µl of the supernatant was placed into a new 1.5mL
Eppendorf tube, while the remaining insoluble material was discarded. Using proper PPE
(goggles, gloves, and a lab coat), 200µl of Chloroform (Fisher Scientific: C606SK-1) was added
in the fume hood to the tube, vortexed for 15 seconds, and then left to incubate at room
temperature for 3 minutes. Tubes were then placed into a Sorvall™ Legend™ Micro 21R
Microcentrifuge (Thermo Fisher Scientific: 75002447) and centrifuged for 30 minutes at 12000g
speed and 4°C. Next tubes were removed carefully and 200µl of the aqueous phase containing
RNA was removed and placed into a new tube, while the rest was discarded. 500µl of isopropyl
alcohol was added to the solution, incubated for 10 minutes, and then centrifuged again for 20
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minutes at 12000g speed and 4°C. The resulting supernatant was then discarded, 1 ml of 75%
Ethanol was added, and the mixture was centrifuged at 7500g speed and 4°C. Again, the
supernatant was discarded, and the remaining material was centrifuged for 10 seconds. Any
additional liquid was removed, and the resulting pellet was left to dry. 50µl of ultrapure distilled
water was added to the pellet, followed by 25µl of a LiCl Precipitation Solution (Thermo Fisher
Scientific: AM9480) and then left to incubate overnight at -20°C. The next morning samples
were defrosted on ice and then centrifuged at max speed for 30 minutes at 4°C. The supernatant
was discarded and then 1ml of 70% ethanol was added before centrifuging again for 30 minutes
at max speed and 4°C. The supernatant was discarded, and the tube was respun for 10 seconds.
The resulting pellet was set to dry for 5 minutes before being resuspended in 30µl of NucleaseFree Water (Thermo Fisher: AM9938). Next, resulting RNA was tested for concentration and
purity before being used in RT-PCR.
In order to quantify expression levels of early cardiac genes and gata1 with ef1-α as a
housekeeping gene (BioMolecular Systems micPCR, using micPCR v2.6.5 software) a Luna®
Universal One-Step RT-qPCR Kit (New England BioLabs: E3005S) was used in which the
generated RNA can be used directly for RT-qPCR experiments. Materials were thawed at room
temperature and then placed on ice. Master mixes were created using 10µl of Luna Universal
One-Step Reaction Mix (2X), 1µl of Luna WarmStart® RT Enzyme Mix (20X), 0.8µl of 10µM
forward primer and 0.8µl of 10µM reverse primer, and 6.4 µl of Nuclease-Free water. After 19µl
of this master mix was placed into the appropriate qPCR tube 1µl of 10ng/µl Template RNA was
added. Samples were placed into the micPCR machine and the following protocol was used. A
single reverse transcriptase phase of 10 minutes at 55°C, a single initial denaturation cycle at
95°C, followed by 45 cycles of a Denaturation stage of 10 seconds at 95°C, an extension phase
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of 30 seconds at 60°C, followed by a single melt curve cycle between 60°C and 95°C. Results
were gathered using the micPCR v2.6.5 software. Primers used were as follows: myocd, 5′-GCC
CAA AGC AAA TTA CAA GAA-3′ (forward) and 5′-GGA AGT CGG TGT TGA AGA TAC3’ (reverse) [53]; dkk1, 5′-TCC CAG AAG AAC CAC ACT GAC-3′ (forward) and 5′-GGT
GCA CAC CTG ACC TTC TT-3′ (reverse); tnni3 5′-CTG CCG ACG CCA TGA TG-3′
(forward) and 5′-GTT TGA GAC TGG CCC GTA GGT-3’ (reverse) [52].
Stage 40 gata1 PCR experimental embryos were exposed to Revel solution according to
the standard exposure protocol (Fig 1), removed at stage 40, and were then placed into 0.1xMBS
and a few drops of Tricaine (Western Chemical: 051819) was added. 30 heads from both the
control and exposed groups were dissected and collected in 800µl of Trizol (Ambion Fisher:
15596026), taking care to avoid including the heart and anything posterior to it. RNA was
generated using the same protocol described above. cDNA was then synthesized using a
Sensifast™ cDNA Synthesis Kit (Bioline Meridian Bioscience: Bio-65054). A master mix was
made for control and Revel treated RNA separately consisting of 4µl of a SensiFast 5x
TransAmp Buffer, 1µl of Reverse Transcriptase, 1µg of RNA, and enough Nuclease-Free water
to bring the total volume of each tube to 20µl. Tubes were placed into a thermocycler set to the
following protocol: an annealing step at 25 °C for 10 minutes, a reverse transcription step at 42
°C for 15 minutes, an inactivation step at 85 °C for 5 minutes, and finally a hold step at 4 °C.
The resulting cDNA was then used in RT-PCR. RT-PCR was performed using a SensiFAST™
SYBR® No-ROX Kit (Bioline Meridian Bioscience: BIO-98005) to quantify expression levels
of gata1 using ef1-α as a housekeeping gene (BioMolecular Systems micPCR, using micPCR
v2.6.5 software.) Primers were suspended in Nuclease-Free water from 100µM stock solutions to
10µM aliquots of 25µl. Master mixes were made using 10µl of 2x SensiFAST™ SYBR® No-
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ROX Mix, 1µl of the template cDNA, and 8µl of dH2O. Primer mixes were made using 0.5µl of
10µM forward primer and 0.5µl of 10µM reverse primer. Once these were created, 19µl of the
Master mix was added to a qPCR tube, followed by 1µl of the appropriate primer mix. Results
were gathered using the micPCR v2.6.5 software.
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3. Results

3.1 Revel exposure causes alterations in heart morphology
To assess heart morphology the heart was imaged at stage 45 when the looping process is
complete and septation has occurred in the atria, resulting in the three individual chambers of the
heart being formed. Basic light microscopy, as well as immunofluorescence using an antibody
that binds to a heart-specific muscle protein, cardiac troponin (Tnni3), was used.
In Revel exposed embryos, altered heart morphology was observed using both
techniques. Specifically, the ventricles were smaller, and the position of the ventricle and
outflow tract appeared different than in controls. (Fig 2 A-H.) Outflow tracts in the Revel
exposed embryos lacked the distinct curvature observed in all controls often making the hearts
appear longer (Fig 2 B, D)
To quantify differences in heart size, measurements of ventricle diameter, from anterior
to posterior in a ventral view were recorded(Fig 2 A, C.) A statistically significant difference
was found between the embryo ventricle diameters of exposed (N=30) compared to control
(N=41) embryos (student t-test, p-value = 0.009) (Fig 2 J.) To further compare the changes in
heart size between the two groups a categorical analysis where the ventricle diameter of each
embryo was equally categorized into large, medium, small, and extra small was created. Each
category was then visualized on a stacked bar graph in an attempt to better see trends in the data.
Results indicate that 37% of the Revel exposed embryo ventricle measurements fell into the
“small” range (230.36 µm to 285.54 µm), compared to only 11% of the control. None of the
control embryos fell into the “extra small” range (175.19 µm to 230.35 µm), while 16% of Revel
exposed embryos did (Fig 2 I.) Additional differences in morphology were apparent as the Revel
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exposed embryo hearts tended to appear “longer,” and more random in orientation, perhaps due
to the disrupted looping patterns.
Together, the results indicate that Revel exposure causes defects in the morphology of the
heart, specifically in the size of the ventricle.

3.2 Revel exposure reduces heart rate
To assess the function of the heart, I used light microscopy to measure heart rates of both
Revel exposed and control embryos. A statistically significant reduction in heart rate was
observed in Revel exposed embryos (N=60) when compared to the unexposed controls (N=60),
with a relative decrease of 14% (3 biological replicates, Mann-Whitney Rank Sum, P = <0.001)
(Fig 2 K.) A categorized analysis and stacked bar graph revealed that of the Revel exposed
embryos, 42% were shown to have a decreased heart rate in a range (110.4-131.6 bpm) that fell
below any of the control specimens (Fig 2 L.) Additionally, ventricle contraction in Revel
exposed embryos at times appeared sporadic and less uniform than the controls.
These results indicate that in addition to morphological malformations, Revel exposure
also causes a reduction in heart rate.

3.3 Exposure to neat and aerosolized e-liquid solution preparations have similar effects
Next, to determine whether the process of aerosolization alters e-liquids in such a way
that could affect the heart differently, sibling embryos were exposed to both aerosolized and neat
Revel. Preliminary experiments in the lab were performed to test various concentrations of each
preparation and it was determined that 1:100 dilution of aerosolized had almost identical effects
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as a 1:1000 dilution of neat Revel [1]. This is consistent with calculations of nicotine
concentrations in the aerosolized Revel preps.
Whole embryos exposed to neat and aerosolized Revel each showed similar reductions in
overall length and a curved body axis when compared to controls. Also, similar levels of edema
in the anterior portion of the embryo, as well as gut abnormalities, were observed in embryos
exposed to both preparations, and absent in controls. In both preparations, e-liquid exposure led
to a phenotype in which the eyes were located closer together when viewing dorsally. Similar
lens defects in the eye were also observed in both groups, but absent in controls (Fig 3 A-C.)
To determine if the heart ventricle size was affected in the same way by both
preparations, ventricle sizes were measured from a ventral view as mentioned above. There was
an apparent reduction in the ventricle size when visualized using light microscopy (Fig 3 D-F.)
To visualize the relationship between ventricle size between the two groups I performed a
categorial analysis and created a stacked bar graph with a small sample of embryos (n=36, 1
replicate). 75% of control embryos fell into a range of 294.67µm and 346.00µm, compared to
only 23% of aerosolized, and 14% of neat e-liquid exposed embryos. Roughly 70% of both the
aerosolized and neat exposed embryos fell into a range of 242.33µm and 293.67µm, compared to
only 25% of the control. Finally, 8% of the aerosolized Revel and 14% of the neat Revel exposed
embryos fell into the smallest range of 190µm and 241.33µm, while none of the controls were
found to be that small (Fig 3 G.)
Together, these results suggest that the effects of e-liquid exposure are similar regardless
of the preparation. Most importantly, concerning the observed decreases in heart size and heart
rate in this study, the effects of the teratogenic chemicals observed do not seem to be different
when the e-liquid is aerosolized.
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3.4 Exposure to neither neat nicotine nor a solution of aerosolized nicotine, propylene glycol,
and vegetable glycerin reduced ventricle size or heart rate
To determine whether the observed changes in heart morphology and function recorded
were due to additives in the Revel flavorings or due solely to nicotine and other common carrier
fluids in e-liquids. To assess this, sibling embryos were exposed to a neat preparation of nicotine
and an aerosolized mixture of nicotine, propylene glycol, and vegetable glycerin (referred to as
nicotine+PG+VG.) Light microscopy and immunofluorescence using an antibody that binds to
Troponin, a cardiac-specific muscle protein, were used to evaluate heart rate and ventricle size in
these embryos compared to controls.
No significant difference was found in ventricle diameters between the embryos exposed
to neat nicotine, nicotine+PG+VG, or control embryos (Kruskal-Wallis One Way Analysis of
Variance on Ranks, p-value = 0.418) (Fig 4 B.) Ventral images of control, nicotine, and
nicotine+PG+VG exposed embryos showed no observable difference in ventricle size, shape, or
orientation (Fig 4 C-E.)
Similarly, no significant difference was observed in the heart rate between neat nicotine,
nicotine+PG+VG, and control embryos (Kruskal-Wallis One Way Analysis of Variance on
Ranks, p-value = 0.533) (Fig 4 A.)
These results indicate that neither neat nicotine nor nicotine plus the common e-liquid
additives Propylene Glycol and Vegetable Glycerin had significant effects on heart morphology
or heart rate.
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3.5 Revel exposure alters vascular organization
To assess any alteration in developing vasculature in embryos exposed to Revel I utilized
a transgenic line in which GFP is driven by the flk1 promoter. flk1 is expressed in the developing
vasculature and therefore allows visualization of GFP in the blood vessels.
Unexposed control embryos showed a consistent and mostly symmetrical vascular
network in the orofacial region across 100% of specimen. While there was some observable
vasculature supplying the face in experimental embryos, what resulted was a spectrum of
phenotypes. Only 20% of embryos appeared to have similar vascular networks and branching
patterns when compared to controls. The remaining 80% had varying numbers of vessels present,
and the patterns of vascular branching were less organized in mild phenotypes. In some more
extreme phenotypes, large parts of the network seemed to be absent altogether. Edema was
noted in the anterior portion of 80% of exposed embryos. On the whole, experimental embryos
were shown to be of a reduced size when compared to controls (Fig 5 I-L.)
These results suggest that e-liquid exposure does, in fact, alter vasculature development.

3.6 Revel exposure alters the localization of blood in embryos

3.6a) O-Dianisidine staining
To assess the effect that e-liquid had on the location of blood in the orofacial region of
exposed embryos, I used light microscopy and O-Dianisidine staining to detect hemoglobin [42].
100% of control embryos had vivid networks of O-Dianisidine labeling in the face, and
from most ventral and dorsal views there was extensive vascular branching to other areas around
the craniofacial region (Fig 5 A.) By contrast, 87% of Revel exposed embryos had little or no O-
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Dianisidine labeling in the head accompanied by excess labeling near the heart and digestive
system (n=80, 4 biological replicates) (Fig 5 B-C.) The remaining 13% of Revel exposed
embryos that had staining were still distinct from the control group. In these embryos, a random
scattering of blood cells with no real consistent pattern in location was observed (Fig 5 D). These
embryos showed similar signs of blood pooling around the gut or tail.
These results suggest that e-liquid exposure alters the amount of hemoglobin containing
red blood cells present in the orofacial region of developing embryos.

3.6b) GATA1 Transgenic blood marker
To confirm that there was indeed a difference in blood localization in embryos exposed to
Revel I next used another technique to visualize blood cells. Here I utilized a GATA1 transgenic
line that expresses GFP in circulating blood cells. Individual blood cells were imaged as they
moved throughout the embryo in real-time. Conserved networks of moving fluorescing cells
marking the presence of Gata1 expression was observed in 100% of control embryos (Fig 5 E.)
However, while exposed embryos did show varying amounts of blood cells anterior to the gut,
only 61% of them had similar levels to those of the control. Further, of that 61% of exposed
embryos, the observed branching patterns lit by Gata1 in blood cells were not as conserved and
appeared more random when compared to controls (Fig 5 H.)
The remaining 39% appeared to have far lower numbers of blood cells in the orofacial
region, with many of the conserved branching patterns of the controls completely absent (Fig 5
F, G.) Using RT-qPCR, the micro-dissected faces of Revel exposed embryos at stage 40 showed
a reduction in the level of gata1 expression in the orofacial region, with a fold change of 0.58
(student t-test, p-value = 9.91 x 10-6) (Fig 5 M.)
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3.7 Revel exposure alters the expression of regulatory genes prior to the start of circulation

3.7a) Blood regulator GATA1
One could hypothesize that the changes in blood distribution could simply be due to a
reduction in heart function and/or vascular malformation. On the other hand, the observed
changes in blood localization could be due to a reduction in the expression of genes that regulate
hematopoiesis and erythropoiesis. Therefore, to test this, I measured the level of an important
blood regulator GATA1 using RT-qPCR. Relative levels of GATA1 were measured at stage 30
(35 hpf), a time when the blood islands are forming and GATA1 is vital for proper blood
development as red blood cell differentiation has begun. Alterations during this time could
negatively affect both the proliferation and viability of RBCs.
GATA1 levels in Revel exposed embryos were reduced at stage 30 by a fold change of
0.33 relative to housekeeping (student t-test, p-value = 0.000715) (Fig 6 A)
The results from this experiment indicate that Revel exposure reduces GATA1
expression, most importantly concerning development, at a time when it is critical for initial
erythropoiesis.

3.7b) Heart development regulators: myocd, dkk1, and tnni3
I next asked if the reductions in ventricle size and heart rate were due to the effects of
Revel on the early development of the heart. To assess this, expression levels of genes integral
to heart development were measured. RT-qPCR was used to quantify relative expression levels
of a gene necessary for early development (dkk1), a transcription factor required for
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cardiomyocyte differentiation (Myocd), and a gene that when transcribed is a protein necessary
for heart cell contraction (tnni3) in Revel exposed embryos at stage 30 (35 hpf). Stage 30 was
chosen because at this stage the primary heart tube is beginning to form and soon the looping
process will begin. Assessing any alterations in the expression of important regulatory genes and
transcription factors at this state would help to clarify the effect that e-liquid exposure has during
critical developmental stages.
Revel exposed embryos showed a reduction in the level of expression of all three genes
in whole embryos: tnni3 with a fold change of 0.59 (student t-test, p-value = 0.0193), dkk1 had a
fold change of 0.02 (student t-test, p-value = 2.64 x 10-8), and myocd had a fold change of 0.27
(student t-test, p-value = 0.0456) (Fig 6 B.)
The results of these RT-qPCR experiments indicate that Revel e-liquid exposure reduced
the expression levels of genes important for heart development.
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4. Discussion

The present work details the effects of an e-liquid containing popular flavors on
cardiovascular morphology, heart function, and gene expression. Further, I begin to examine the
effects this e-liquid has on the development of vasculature and blood. Additionally, it was
assessed whether the observed defects were due solely to nicotine in combination with common
inert carriers or instead caused some other substances in the e-liquid solution, perhaps flavoring
additives. Finally, whether there is something in the aerosolized form that results in different
phenotypes from the neat preparation was investigated.
This work demonstrates the potential dangers of ECIG use during development,
specifically the risks associated with heart defects. Due to the previously established link
between traditional cigarettes and their negative effect on development and increased risk of
CHDs, the importance of examining the effects of ECIG exposure on cardiovascular
development is paramount.

4.1 The effects of e-liquid exposure on cardiovascular development

4.1a) Examining the effects of e-liquid exposure on heart morphology
Revel exposure resulted in abnormal heart morphology in X. laevis embryos. The heart
ventricles were smaller, and an aberrant arrangement of the heart was seen. These observations
are consistent with previous reports of e-liquid and cigarette exposure on zebrafish [14]. X.
laevis embryos were exposed over a period of heart development so this effect is not likely due
to non-specific effects at gastrulation. I also determined that genes required in the early induction
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of the heart and later differentiation of cardiomyocytes were reduced. This is consistent with
previous studies that have established that e-liquid exposure reduced the expression of
transcription factors in immature cardiac cells leading to a disruption in the timing of cardiac cell
differentiation [14]. Therefore, the reduction in ventricle size and abnormal heart morphology
could be due to a decrease in the number of viable heart cells that differentiate. The proper
morphology might be dependent on having sufficient tissue. Alternatively, other genes required
for proper heart looping may be disrupted. While the initial contractions of the cardiac muscle
play an important role in triggering the looping process, the continued contractions may play a
supporting role in other factors affecting morphogenesis [51]. Research suggests that the actual
flow of blood, powered by the developing heart, has a substantial effect on the process of heart
development, specifically in embryos. While the overall mechanism has not yet been determined,
certain processes and genes that specifically respond to blood flow continue to be discovered
[50]. This helps to illustrate the importance of proper conservation of these key processes, which
seem to be disrupted in those embryos exposed to e-liquid solution in this study.
Further, the alterations in ventricle morphology may be due to the disruption of early
cardiac gene expression around the time of heart tube formation. Proper development of the heart
relies on the synergistic cooperation of several important genes and transcription factors [56]. X.
laevis embryos exposed to an e-liquid solution had a reduction in the expression of three genes
that regulate cardiac development.
The expression of one gene reduced by e-liquid exposure was dkk1. dkk1 expression
levels in embryos exposed to e-liquid were 98% lower. dkk1 is an important gene that codes for a
protein that acts to inhibit Wnt signaling during cardiogenesis to ensure proper cardiac cell
differentiation. Wnt/β-catenin signaling plays a crucial regulatory role in several phases of heart
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development due to its ability to bind to its receptor, influence gene expression, and in doing so
activate a multitude of signaling pathways [52]. Throughout development, levels of canonical
Wnt/β-catenin signaling are tightly regulated and will change depending on the stage. For
example, while canonical Wnt/β-catenin signaling is first necessary to ensure the formation of
mesoderm and the proliferation of cardiomyocytes in the heart, it must be lowered to ensure that
cardiac specification and differentiation are carried out correctly. dkk1 knockdown experiments
resulted in a reduction in outflow tract, atria, and ventricle size as well as a significant reduction
in the heart rate [52]. Similarly, embryos that were exposed to Revel e-liquid solution had a
smaller ventricle size and slower heart rate. Thus, these defects could be attributed to e-liquid
chemical(s) modulating dkk1 expression.
Levels of myocd expression were reduced by 73% in embryos exposed to eliquid. myocd is expressed exclusively in cardiac and smooth muscle throughout development.
Myocd plays a role in early heart development, cardiac cell differentiation, as well as smooth
muscle vasculature differentiation. It does this by being a transcriptional co-activator of serum
response factor (SRF) that regulates the expression of heart and smooth muscle-specific SRFtarget genes, making it important for the differentiation of smooth muscle and heart development
[89]. Myocd is an important transcription factor for the initiation of cardiac gene expression as
overexpression of this gene was shown to cause ectopic expression of multiple heart-related
genes [55]. Knockdown of myocd in X. laevis resulted in the complete absence of cardiac
differentiation as well as disruptions in the normal morphogenic movements that take place
during the formation of the heart tube [53]. This reduction suggests that the e-liquid effects on
heart morphology could be due to the lack of differentiation of the cardiac muscle. The reduction
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in myocd expression in embryos exposed to e-liquids could be one reason why the heart is
smaller and malformed, due to the lack of differentiation of the cardiac muscle.
Finally, the third gene reduced in my expression analysis of embryos exposed to an eliquid was tnni3 whose expression was reduced by 41%. The Tnni3 protein is exclusively
expressed in cardiac muscle tissues and is a definitive cardiac marker that is commonly used to
test for altered morphogenesis [54]. tnni3 knockdown studies in mice resulted in death within
two weeks, due to a decrease in both the size and function of the left ventricle [75]. Considered
together, the significant decrease in ventricle diameter in embryos exposed to e-liquid could be
due to the disruption of tnni3 expression.
Multiple studies have detailed the detrimental effect that both over and underexpression
of key cardiac genes can have on successful cardiogenesis [52-56]. Revel exposed embryos
showed lower expression levels of all three of the genes examined and displayed similar
phenotypes to those described in knockdown experiments. Therefore, the reduction in ventricle
size and altered heart morphology in embryos exposed to e-liquid may be, at least in part, due to
the misexpression of such key regulatory genes.

4.1b) Examining the effects of e-liquid exposure on heart function
In addition to reduced ventricle size heart function, as assessed by ventricular contraction,
was decreased. Heart rates of Revel exposed embryos showed a significant decrease of 14%
when compared to that of the control. This is consistent with previous studies that have shown
that exposure to e-liquid results in significant decreases in zebrafish heart rate [18]. This
reduction is further demonstrated when analyzing the distribution of the heart rates between the
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two groups. Measurements showed that 42% of the Revel exposed embryos had heart rates that
were below 131.6 bpm, lower than any of the control heart rates in this study.
One explanation for the reduction in heart rate could be due to the observed decrease in
ventricle size as well as the malformed heart structure. As structural morphology is altered, it
stands to reason that the function would undoubtedly be affected. The altered heart rate may be
due to some insurmountable morphological change. Alternatively, I have shown that Revel
exposure leads to a reduction in the expression of Tnni3, a cardiac-specific protein that is
associated with the regulation of heart contraction due to its interaction with the sarcomere [90].
Therefore, the irregularities in heart rate may stem from a lack of this critical protein, reducing
the literal number of viable contractile units within the developing myocardium. Studies in mice
have shown that as cardiac troponin levels were reduced sarcomeres began to shorten altering
function [75]. Additionally, Tnni3 must respond directly with varying calcium levels to maintain
a coordinated rhythm [90]. It is possible that due to the reduced expression levels there is not an
adequate amount of Tnni3 to interact with the cellular calcium leading to irregular contraction
patterns and overall rhythm. This is in line with previous knockdown studies that found that there
was a decreased response to calcium in cardiac troponin depleted in mice [78]. This could
perhaps also explain why Revel exposed embryo heartbeats would appear to be sporadic
compared to the even, rolling contractions of the controls. Experiments in this work also show a
reduction in genes that regulate the differentiation and proliferation of cardiomyocytes, such
as dkk1. As cardiomyocytes are the cells responsible for generating contractile force, the
reduction in heart rate may be due to a lack of these cells. It is also possible that e-liquids cause
disruptions in the physiological environment such as increases in intracellular calcium levels
leading to irregular rhythms and slowed heart rate. E-liquid, as well as nicotine exposure, has
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been shown to lead to increases in mitochondrial calcium levels resulting in altered function in
neural and stem cells [79]. Additionally, neat and aerosolized e-liquid exposure was shown to
alter intracellular calcium levels independent of nicotine in epithelial cells [88]. E-liquid
exposure could have similar effects in other tissues as well. Further, this suggests that calcium
fluctuations are due to chemicals within the e-liquid and not in products formed by combustion.
Further experiments are needed to examine e-liquid exposure and calcium levels in X.
laevis cardiac tissues. Another possibility is that Revel exposure disrupts the natural X.
laevis heart conduction system. Previous studies have shown that X. laevis heart conduction
responds similarly to that of humans in response to multiple cardiac drugs [71]. Further, in
humans, it has been noted that malfunctions in the electrical conduction system often present
themselves alongside malformations in anatomy [71]. It is possible therefore that the disruption
to heart rate is due to malfunctioning pacemaker cells responsible for the electrical conduction in
the cardiovascular system, presenting alongside the noted heart malformations.
More experiments are needed to truly understand why Revel causes defects in heart
morphology and function.

4.2 Clarifying causative agents for the observed alterations in the X. laevis heart

4.2a) Assessing the effects of nicotine on heart morphology and function
I first wanted to assess whether the observed reductions in ventricle size and heart rate
were simply due to nicotine since this chemical is known to alter heart rate in humans [87].
Similarly, my goal was to rule out the possibility that the observed cardiac changes might be due
to a combination of common carrier additives in e-liquid solutions, that might be making

34

nicotine more potent. To test this, embryos were exposed to identical concentrations of a neat
nicotine solution and an aerosolized mixture of nicotine, propylene glycol (PG), and vegetable
glycerin (VG), hereafter referred to as “nicotine+PG+VG,” at levels that were identical to those
in the concentrations of Revel solution used to expose embryos in this study; ventricle diameters
and heart rates were then recorded. No significant difference was found between any of the
ventricle diameters between the groups. Similarly, there was no significant difference found in
the heart rates between any of the groups. There appeared to be no difference in ventricle
orientation, or shape between any of the groups either. These results suggest that other chemicals
in e-liquids are responsible for the changes described in this study. This theory is in line with the
results of previous experiments that have found that popular flavoring additives in e-liquids were
more toxic than PG and VG alone [77]. Further, studies have shown that the cytotoxic effects of
ECIGs were not due to nicotine but instead caused by various flavoring chemicals [43]. These
experiments suggest that at concentrations used in this study, the heart defects in form and
function in embryos exposed to Revel e-liquid solution are not simply due to nicotine, by itself,
or complexed with propylene glycol (PG) and vegetable glycerin (VG). Further experiments are
needed to conclude what specific chemicals are causing these changes, but it is likely due to
chemicals such as those that are used to add flavoring.
Chemicals that provide flavor are numerous and include benzyl alcohol, benzaldehyde,
vanillin [76]. Some flavor additives, such as diacetyl, which lends a creamy flavor to vapor are
currently on the FDA’s Generally Recognized As Safe list [77]. For this reason, diacetyl may
seem safe as it may not cause any detriment when digested, however, when inhaled it causes
bronchitis obliterans [1]. This is partially due to the method of administration, where inhaled
substances avoid the first-pass metabolism, but also because when aerosolized, these substances
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undergo chemical changes that convert them into hazardous compounds [58]. Many of these
chemicals are converted to carcinogens some of which, like benzene, present major danger to
users as well as those exposed to vapor second hand [60]. Chemicals that lend vapor cinnamon
(cinnamaldehyde) flavoring have now been shown to be highly toxic and poisonous to D. rerio
and human stem cells [14].

4.2b) Neat and aerosolized e-liquid exposure results in similar phenotypes
After concluding that nicotine was not the cause for the altered morphology, I wanted to
assess whether there was something different in aerosolized e-liquids that was capable of causing
heart defects. Embryos exposed to either aerosolized or neat Revel appeared very similar
phenotypically, with a shorter axis, curved bodies, and a reduction in ventricle size. The results
of these experiments strongly suggest that neat and aerosolized Revel exposure has similar
effects, at least on heart size and general embryonic morphology. However additional
experiments and quantification would be necessary. The observed similarities in phenotype
between preparations lead me to the conclusion that there is something in the actual e-liquid
itself that goes unchanged when heated, which ultimately results in the alterations. This
conclusion is in line with previous studies that found no difference in relative toxicity in cells
between aerosolized and neat e-liquid exposure [77, 82]. This suggests that despite studies
indicating that propylene glycol (PG) and vegetable glycerin (VG) become harmful substances
like formaldehyde and acetone when heated [85], these chemicals are not responsible for the
reduced ventricle size and heart rates in this study. Interestingly, formaldehyde has been
identified in inhalers used medicinally at similar levels to those found in certain aerosolized eliquids [85]. These results suggest that focusing specifically on chemicals that are altered when
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heated may not hold the key to identifying the compounds that cause these defects in
morphology.
One of the difficulties in identifying the chemicals responsible for the adverse effects of
electronic cigarettes is the high level of variability of their ingredients. In a study that submitted
122 e-liquids to chemical analysis, 171 unique compounds were detected. 41 of the most
common compounds detected carried GHS Warning codes, some indicating reproductive and
organ toxicity [86]. This indicates that the defects observed from e-liquid exposure could be due
to chemicals known to have damaging health effects that are unaltered during the combustion
process during vaping.

4.3 Alterations in blood development and distribution as a result of e-liquid exposure
In this study, I focus on the distribution of blood and vasculature in the head region of X.
laevis embryos, as this is a region of interest in our lab. Additional experiments are required to
fully investigate the effect of e-liquid exposure on developing blood and vasculature in other
areas. Further, previous studies in our lab found that the presence of blood in the trunk and tail of
embryos exposed to e-liquid appeared similar to controls [1]. Thus, I did not examine these areas
deciding to concentrate instead on the head.
My data and previous studies in our lab, found a change in the localization of blood
present in the developing X. laevis embryo face using both a histological stain for hemoglobin
and transgenic embryos carrying a transgene for red blood marker Gata1 at the larval stage. To
further characterize this, I also measured levels of a gata1 expressed in the head using PCR,
noting a 42% reduction in expression. Additionally, while blood was visible in the contracting
ventricle without any staining in almost all of the control embryos, this was not as common in
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exposed groups. Instead, while contractions were evident, the organ remained translucent and
without color. Occasionally this would be accompanied by blood that was visible without stain
pooling around the gut or gills. Gata1 is a transcription factor that codes for two proteins that
bind DNA and regulate the expression of genes that play an important role in the formation and
maturation of red blood cells (RBCs) [30]. Therefore, the reduction in blood cells in the head
might be because the development of the blood itself is altered. Reductions in gata1 expression
were noted during a critical time when blood islands are forming, and red blood cell
differentiation has begun. Any scenario that would lower gata1 expression or inactivate all
together will likely result in one of several deleterious outcomes [4]. First, there may be a lower
overall amount of red blood cells and platelets present. It is also possible that those that are
present will have a reduction in function as the Gata1 transcription factors help to regulate the
maturation of RBCs. Another observed outcome has been a complete lack of these cell types; the
absence of blood. In a previous study, gata1 knockdown mice all died around the 11-day mark as
erythrocyte progenitor cells began undergoing apoptosis and large amounts of immature
megakaryocytes were not able to differentiate into functioning platelets [4].
Alternatively, the number of red blood cells could be reduced in the head because of the
noted alterations in heart size, shape, and function. It is possible that due to this disrupted
morphology, the blood simply is not able to reach the anterior portion of the embryo due to some
loss of contractile strength. Studies in human cardiomyocytes have found that electronic cigarette
exposure resulted in decreases in expression of sarcomeric genes [14]. The sarcomere is the
contractile unit in muscle tissue. Perhaps it goes beyond the just strength of contractions and
instead stems from some insurmountable change to the overall structure that lowers cardiac
output. Previous studies in zebrafish have noted that cigarette smoke exposure resulted in
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reduced ventricle size and heart rate accompanied by a decrease in stroke volume (the volume of
blood pumped systemically by the ventricle) [80]. Chemicals in e-liquid vapor might have
similar effects on cardiac output due to the similarities in ventricle size and heart rate reductions.
It is also possible that though the heart still beats, it does so in a disorganized way that
never achieves full recruitment of cardiomyocytes limiting ejection fraction. Further, it could be
a combination of these two things: a weak contraction that is lacking coordination and regularity.
Finally, the lack of blood in the face may be due in some part to a lack of blood vessel
formation. Many of the Flk1 Transgenic embryos exposed to Revel solution had alterations in
the patterns of the vasculature, with some embryos missing large portions of the observed
networks in controls.
The reduction in blood in the head of embryos exposed to e-liquid is likely due in part to
a reduction in the expression of important transcription factors that regulate blood cell
development. While further investigation is necessary, it might also be caused by a reduction in
the amount of blood the malformed heart can pump systemically.

4.4 The effects of e-liquid exposure on vascular development
To further evaluate the relationship between e-liquid exposure and developing blood
vessels, a vasculature marker, Flk1, that highlights areas of both vasculogenesis and
angiogenesis was used. Most of the Flk1 Transgenic embryos that were exposed to Revel
solution had variances in the patterns of the vasculature, notably with a reduction in the overall
amount of blood vessels present. This apparent reduction in vasculature could be due to
alterations in gene expression that play a role in vascular development. Previous studies noted a
reduction in VEGF, a vascular differentiation marker, in embryos exposed to e-liquid [1]. When
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addressing the observed lack of blood cells in the head, many embryos exposed to e-liquid were
missing large portions of the observed vascular networks in controls entirely. This may be due in
some part to a disruption during development that simply resulted in a lower number of blood
vessels forming. Cigarette condensate was shown to disrupt vascular patterns and cause
extensive hemorrhaging in chick embryos [81]. Chemicals in e-liquids could be capable of
similar disruptive effects. Also, e-liquid exposed groups consistently exhibited edema proximal
to the heart. The lack of blood in the face may not simply be due to a reduction in viable blood
cells, but perhaps disrupted networks of vasculature that are “leaky” leading to the observed
blood pooling near the gut of some embryos.
Another possible explanation for the apparent reductions in vasculature could be traced
back to gata1. Again, Gata1 levels were reduced at early developmental stages when angioblasts
are first beginning to migrate and begin to differentiate into the strands of cells that will go on to
form tubes and then the primary plexus. Gata1 plays an important role in the expression of an
angiogenic factor (AGGF1) that promotes endothelial cell proliferation, and when AGGF1
expression levels are altered results in vascular defects [5]. gata1 knockdown cultures were
observed to have significant decreases in this angiogenic factor that led to apoptosis of the cell
layer that lines the interior of blood vessels, and the inhibition of the formation of capillaries
from endothelial cells [5]. Therefore, the reduction in blood vessels could be due to the alteration
of genes that play important roles in the formation and maintenance of endothelial cells that will
eventually become the vasculature.
Alternatively, the observed changes in the appearance of vascular networks could be due
to something other than the direct development of the vessels themselves. Revel liquid exposure
may alter the environment in which the endothelial sheets begin to form tubes by disrupting the
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Retinoic acid gradient at these stages. Previous studies have shown that disruptions in the
retinoic pathway can lead to malformation of the major vessels as well as the outflow tract of the
heart [72].
The results of this transgenic experiment suggest that there is a disruption and a reduction
in the vascular network supplying the head. Further experiments need to be done to determine if
levels of flk1 expression are altered.
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5. Conclusion

Based on the data collected in this work I am proposing a mechanism of how e-liquids
exposure could be affecting various aspects of cardiovascular development.
E-liquid exposure alters regulatory genes and transcription factors during critical
developmental stages when the earliest cardiac cells are differentiating, and structures are
forming. These disruptions result in morphological changes that include a reduction in ventricle
diameter. These changes are not limited to size, but include composition, with alterations in the
number of functional contractile cells that result in an alteration in heart rate. This early pattern
of disruption does not rule out the potential for other detrimental effects in later developmental
patterning and physiology.
Further, e-liquid exposure reduces the expression of transcription factors that are critical
for the establishment of the embryonic blood cell lineages and the maintenance of these
immature blood cells as they mature. This reduction results in a decrease in the number of viable
cells, and ultimately a lack of blood as progenitor cells are unable to differentiate and avoid
apoptosis.
Further, I suggest that e-liquid exposure alters signaling pathways during vasculogenesis
and angiogenesis that disrupt the formation of functioning capillary networks and instead results
in a disorganized network of blood vessels that are leaky, resulting in edema and blood pooling
around the gut and tail.
The result of these events culminates in defective heart morphology, a reduction in
cardiac function, and reduced blood flow in the head (Fig 7).
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These cardiovascular changes help to highlight the dangers of ECIG use during
pregnancy, as the same disruptions observed in X. laevis could translate to similar defects in
humans. Due to the use of chemical ingredients suspected to cause damage to the developing
fetus, certain e-liquids and vapors have the potential to disrupt a myriad of developmental
processes. As the risk of congenital heart defects increases with prenatal cigarette use, the
changes in heart form and function in this study indicate that ECIGs could present similar
hazards. In addition to being dangerous on their own, defects due to ECIGs could become even
more severe in dual users of both traditional and electronic cigarettes. Further, as we learn more
about the variety of e-liquid ingredients, there is the potential for interactions with other
substances such as alcohol that are yet unseen.

43

6. Future Directions
6.1 To determine which components of e-liquid solution cause cardiovascular defects
I have shown that electronic cigarette exposure results in a reduction in X. laevis
ventricle size and heart rate, as well as variability in positioning. The observed heart defects were
shown not to be caused by nicotine or inert humectants alone. Further studies need to be done to
try to determine what specific ingredient(s) in Revel e-liquid could be causing the alteration in
form and function observed. These ingredients could be tested independently as well as in
synergistic experiments.
I have done some preliminary work examining exposure to a common e-liquid flavoring
component, vanillin, to get a precursory idea of its effect on development. Exposed embryos
exhibited edema that was so extreme it caused them to have a spherical appearance, impairing
their ability to move. Also, hearts in exposed embryos were arranged in such a way that seemed
longer, and “uncoiled”. Heart rates were detected, but not assessed. Due to the elongated heart
phenotype, it was difficult to judge the efficacy of contractions in most embryos as blood did not
seem to settle in any specific part of the anatomy before moving to the next. Further, eyes were
closer together when compared to controls. Shorter axis and body curvatures similar to Revel
exposed embryos were also detected.
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6.2 To determine the effects of nicotine and inert carriers on blood and vasculature
development
Though nicotine did not appear to cause the observed changes in heart morphology or
function, I cannot rule out the possibility that it is still altering blood development and
vasculature in some way. Previous studies have found that nicotine exposure resulted in a
significant increase in both VEGF mRNA and proteins in pigs. Increases in VEGF have been
shown to result in increases in angiogenesis as well as increased permeability of forming
vasculature [73]. Similarly, some studies in zebrafish found that exposure to nicotine in total
particulate matter from traditional cigarettes results in a decrease in the number of blood vessels
supplying the brain [74]. It is possible that, despite seeing no difference in cardiac phenotype,
blood and vasculature were still affected. To assess whether or not nicotine or nicotine+PG+VG
altered blood development and vasculature, similar PCR and Transgenic experiments to those in
this study could be conducted.
To evaluate changes in vasculature development, levels of VEGF expression in nicotine
and nicotine+PG+VG exposed embryos could be examined through the use of RT-qPCR at
multiple stages. For example, stage 22 when VEGF is responsible for the formation of
hemangioblasts, stage 27 when VEGF influences migration and differentiation of angioblasts,
and finally stage 46 when principal blood vessels have finished forming.
In this work, I showed a decrease in gata1 associated with a reduction in the number of
blood cells present. To evaluate the effects of nicotine and inert carriers on blood development,
gata1 levels in these embryos could be investigated as well, at stage 30 when the blood islands
are forming and stage 40 when the dorsal aorta has formed. Alternatively, to visualize any
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reductions in blood cells or blood vessels, transgenic lines could be used that would allow these
structures to be visualized using fluorescent microscopy.

6.3 To better understand the mechanisms by which e-liquid exposure causes cardiovascular
malformations
I have shown that e-liquid exposure during development resulted in altered heart
morphology including a reduction in ventricle size as well as decreases in heart function.
Embryos exposed to Revel solution continually showed phenotypes in which the heart appeared
long and “unwound.” Further studies need to be done to determine the specific mechanism that
leads to the observed malformations. The results of this study suggest a few possibilities. First, eliquid exposure may alter the expression of regulatory genes during cardiogenesis that ultimately
leads to the observed morphological anomalies. Second, e-liquid exposure might alter structures
that then, in turn, results in some alteration in gene expression similar to those observed in this
study. These changes could then lead to further morphological change. Similarly, decreases in
heart function at early stages could lead to disruption in the later stages of development. To
elucidate this cause and effect relationship the experiments performed in this study would need
to be extended in scope to include other cardiogenic regulatory genes over many more stages.

46

Figures

Figure 1. Schematic of e-liquid exposure Experimental solutions were added at stage 20-24. Embryos were
then incubated at 23°C until stage 30 for early PCR experiments or stage 40 where they were washed in
0.1xMBS. At this point, depending on the specific aim, embryos were either left to mature to stage 45, or
fixed and dissected for GATA1 RT-PCR. Embryo images: adapted from Nieuwkoop and Faber (1994) Normal
Table of Xenopus laevis (Daudin). Garland Publishing Inc, New York ISBN 0-8153-1896-0 and Karimi K,
Fortriede JD, Lotay VS, et al. Xenbase: a genomic, epigenomic and transcriptomic model organism database.
Nucleic Acids Res. 2018;46(D1):D861–D868. doi:10.1093/nar/gkx936
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Figure 2. Effects of Revel e-liquid exposure on Heart morphology and function
(A-D) Representative fluorescent microscope images with Anti-troponin labeling of cardiac protein (green) in
representative images showing ventral and lateral views in controls. (A, C) Red lines model how ventral
ventricle measurements were taken. (E-H) Representative light microscope images showing ventral views of
controls (E, G) and Revel exposed (F, H) embryos. (I) Distribution of ventricle diameter measurements (µm)
among groups. (J) Ventricle diameters (µm) of experimental groups (n=71, student t-test, p-value = 0.009)
(K) Relative changes in heart rate (bpm) in control and Revel exposed embryos (n=120, 3 biological
replicates, Mann-Whitney Rank Sum, P = <0.001) (L) Distribution of heart rate measurements (bpm) among
groups. Abbreviations: OT = outflow tract, V = ventricle, G = gut
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Figure 3. Effect of neat Revel vs aerosolized Revel exposure on X. laevis heart morphology.
(A-C) Representative light microscope full embryo images displaying typical phenotypic body length and
body angle of control, neat and aerosolized exposed embryos. (D-F) Representative light microscope images
showing ventral views of controls (D), neat Revel exposed (E), aerosolized Revel exposed (F) with ventricles
outlined in red. (G) Distribution of ventricle diameter measurements among groups.
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Figure 4. Neat nicotine and nicotine+PG+VG effect on heart morphology and function
(A) Relative heart rates (bpm) in nicotine+PG+VG and neat nicotine compared to control (n=60, 1 replicate,
Kruskal-Wallis One Way Analysis of Variance on Ranks, p-value = 0.533) (B) Ventricle diameter
measurements in control, nicotine+PG+VG, and neat nicotine exposed embryos (n=60, 1 replicate, KruskalWallis One Way Analysis of Variance on Ranks, p-value = 0.418) (C-E) Representative light microscope
images showing ventral views of controls (C), nicotine+PG+VG exposed (D), neat nicotine exposed (E) with
ventricles outlined in red. Abbreviations: OT = outflow tract, V = ventricle
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Figure 5. o-Dianisidine and Transgenic experiments A-D) Light microscope images of control (A) and
Revel Exposed (B-D) embryos using an o-Dianisidine stain to detect blood. E-H) Fluorescent microscope
images of control (E) and Revel (F-H) exposed Transgenic Gata1-GFP embryos used to detect blood. I-L)
Fluorescent microscope images of control (I) and Revel exposed (J-L) Transgenic FLK-GFP X. laevis
embryos used to detect vasculature. (M) Relative fold change of gata1 expression as determined by qPCR at
stage 40 (n=30, 3 replicates, student t-test, p-value = 9.91 x 10-6)
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Figure 6. E-liquid exposure PCR Experiments
(A) Relative fold change of GATA1 expression as determined by qPCR at stage 30 (n=40, 1 replicate, student
t-test, p-value = 0.000715) (B) Relative fold change of multiple heart gene expression levels at stage 30.
(N=40, 1 replicate) tnni3 fold change of 0.59 (student t-test, p-value = 0.0193), dkk1 fold change of 0.02
(student t-test, p-value = 2.64 x 10-8), and myocd fold change of 0.27 (student t-test, p-value = 0.0456)
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Figure 7. Model of e-liquid Exposure on Cardiovascular Development
Schematic summary of the proposed model outlining the effects of Revel exposure on cardiovascular
development in Xenopus laevis. Embryo images adapted from Nieuwkoop and Faber (1994) Normal Table of
Xenopus laevis (Daudin). Garland Publishing Inc, New York ISBN 0-8153-1896-0 and Karimi K, Fortriede
JD, Lotay VS, et al. Xenbase: a genomic, epigenomic and transcriptomic model organism database. Nucleic
Acids Res. 2018;46(D1):D861–D868. doi:10.1093/nar/gkx936
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Table 1. Important Developmental Events in Heart, Vasculature, and Blood Development
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